ImmunityBio, Inc. (IBRX) Presents at UBS Global Biopharma Conference 2026 Prepared Remarks Transcript
ImmunityBio CEO Richard Adcock presented prepared remarks at the UBS Global Biopharma Conference 2026. The excerpt identifies the company and conference participants but does not include the substance of the remarks.
Why it matters — IBRX watchers can note the company’s participation in the conference, though the excerpt provides no business or clinical updates.